Retiro De Equipo (Recall) de Thioglycollate Broth 5mL. An in vitro diagnostic medical device (IVD)

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Thermo Fisher Scientific Australia & New Zealand.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    RC-2014-RN-01152-1
  • Clase de Riesgo del Evento
    Class II
  • Fecha de inicio del evento
    2014-10-23
  • País del evento
  • Fuente del evento
    DHTGA
  • URL de la fuente del evento
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    Thermo fisher's investigations found that some vials within some boxes within this batch may fail to support the growth of clostridium sporogenes.Continued use of this lot could result in failure to detect this or similar anaerobes.
  • Acción
    Pathology laboratories are requested to inspect their stocks and remove from further use all units from the affected batch number. Requirement for review of patient results should be determined by the laboratory director. This action has been closed-out on 03/06/2016.

Device

Manufacturer